Tennan competitive analysis

Explore patent oppositions filed by Tennan against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Jan 22, 2026
Patent NumberTitleApplicantOpposition Date
Chimeric Antigen Receptors Targeting B-Cell Maturation AntigenTHE UNITED STATES OF AMERICADec 31, 2025
Method And Compositions For Cellular ImmunotherapyFRED HUTCHINSON CANCER CENTEROct 8, 2025
Method Of Treating Or Ameliorating Metabolic Disorders Using Glp-1 Receptor Agonists Conjugated To Antagonists For Gastric Inhibitory Peptide Receptor (Gipr)AMGENJun 16, 2025
Mutated Glycoprotein Of Vesicular Stomatitis VirusCENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRSMay 14, 2025
Methods For Preventing Or Treating Allergy By Administering An Il-4R AntagonistREGENERON PHARMACEUTICALSApr 30, 2025
Methods For Treating Atopic Dermatitis By Administering An Il-4R AntagonistREGENERON PHARMACEUTICALSJan 24, 2025
Device For Dispensing A Fluid Product, And Method For Filling And For Plugging SameAPTAR FRANCEDec 12, 2024
Methods Of Producing Recombinant ProteinsBRISTOL MYERS SQUIBBNov 26, 2024
Compositions, Articles Of Manufacture And Methods Related To Dosing In Cell TherapyJUNO THERAPEUTICSNov 12, 2024
Methods For Treating Severe Atopic Dermatitis By Administering An Il-4R InhibitorREGENERON PHARMACEUTICALSNov 6, 2024

Explore Tennan's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Jan 22, 2026
Patent NumberPublication DateTitleTotal Oppositions
Mar 12, 2025A Parcel Transport Container, Assembly And Monitoring System1

Latest PTAB cases involving Tennan

Discover the latest PTAB cases involving Tennan, highlighting their recent legal challenges and patent disputes.

Last updated on: Jan 26, 2026
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Tennan

IPR2021-00602Mar 9, 2021TENNANTOXYGENATOR WATERInstitution Denied
IPR2021-00625Mar 9, 2021TENNANTOXYGENATOR WATERFinal Written Decision - Appealed

Peer Comparison New

IP litigation analysis comparing Tennan with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Jan 22, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
BOULT WADE TENNANT54 - - -
DANA FARBER CANCER INSTITUTE - 1431
REGENERON PHARMACEUTICALS3894931
SANOFI BIOTECHNOLOGY - 51 - -